OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

News

Prior Information Notice publication

Prior Information Notice publication

The prior information notice (PIN) has been published and announces an open market consultation (OMC) and provides information about the planned pre-commercial procurement (PCP) carried[…]
Read More
Our participation in the VIB conference: « Revolutionizing Next-Generation Sequencing » 11-12 March 2021 (virtual edition)!

Our participation in the VIB conference: « Revolutionizing Next-Generation Sequencing » 11-12 March 2021 (virtual edition)!

This conference aims to bring together experts in both established and novel sequencing technologies along with top scientists in the field. We were glad to[…]
Read More
Page 3 sur 3«123

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer